Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmissible spongiform encephalopathies: vaccine issues.

N R Cashman1

  • 1Department of Medicine (Neurology), Center for Research in Neurodegenerative Diseases and Sunnybrook and Women's College Health Sciences Center, University of Toronto, Ontario, Canada.

Developments in Biologicals
|January 5, 2002
PubMed
Summary

Transmissible spongiform encephalopathies (TSEs) threaten human and animal health. Strategies are needed to eliminate TSE agents in vaccines and ensure product safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prion-like nature of amyotrophic lateral sclerosis.

Progress in molecular biology and translational science·2020
Same author

Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Propagated protein misfolding: New opportunities for therapeutics, new public health risk.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Pathophysiology and diagnosis of post-polio syndrome.

NeuroRehabilitation·2014
Same author

Gerstmann-Straussler-Scheinker disease due to a novel prion protein gene mutation.

Neurology·2011
Same author

Accessibility of a critical prion protein region involved in strain recognition and its implications for the early detection of prions.

Cellular and molecular life sciences : CMLS·2008

Area of Science:

  • Veterinary Medicine
  • Neuroscience
  • Biotechnology

Background:

  • Bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob Disease (vCJD) highlight the persistent risk of transmissible spongiform encephalopathies (TSEs).
  • Iatrogenic transmission of TSE agents through vaccines is a significant public health concern.
  • Ensuring vaccine safety requires addressing potential TSE contamination in all vaccine components.

Purpose of the Study:

  • To outline essential strategies for preventing TSE agent transmission in vaccine production.
  • To emphasize the need for validating the safety of vaccine components and final products against TSEs.

Main Methods:

  • Review of current understanding of TSE agent properties and transmission routes.
  • Identification of critical control points in vaccine manufacturing.

Related Experiment Videos

  • Discussion of potential inactivation and validation methodologies.

    • Main Results:

    • TSE agents can contaminate cellular substrates, media components, enzymes, and excipients.
    • Effective strategies must target the removal or inactivation of TSE agents at multiple stages.
    • Robust validation methods are crucial for confirming the safety of vaccine components and final products.

    Conclusions:

    • Developing effective strategies to obviate TSE agent infectivity is paramount for vaccine safety.
    • Efficient validation protocols are necessary to ensure the safety of vaccines intended for human and animal use.
    • Ongoing vigilance and research are required to mitigate the risk of TSE transmission in biological products.